News
Dr. Kirk Hevener Awarded R21 to Study C. difficile Therapy
www.iths.org
ITHS Rising Star Dr. Kirk Hevener was awarded an R21 grant to investigate a bacterial enzyme as a novel, druggable target for therapy of C. difficile.
Repurposing An Existing Drug for C. difficile Therapy – ITHS
www.iths.org
Dr. Kirk Hevener, an ITHS Rising Star, hopes to find a new treatment for C. diff. infections by repurposing a drug that is already on the market.
Achievements by Treasure Valley people at work: November-December...
www.idahostatesman.com
The latest job changes, promotions, recognition and other achievements in Treasure Valley business, government, education and nonprofits.
sorted by relevance / date